Legal Practice Areas
From the lab to the patient, life sciences, healthcare have a challenging legal landscape. We understand today’s complex business and regulatory environments around the world. Our award-winning lawyers combine subject matter expertise with deep sector knowledge so that we can help with all your legal needs.
Our clients span the full life sciences ecosystem, from suppliers and distributors, contract research organizations and diagnostics companies, through to pharmaceutical and medical device manufacturers, biotech and healthtech innovators, as well as investors, payers and care providers. We are frequently exposed to the latest innovations, including mRNA vaccines, new cell and gene therapies, cutting-edge healthtech and psychedelic therapeutics. Whether you’re a large pharmaceutical, mid-sized medical device or startup biotech company, our global team can help you succeed.
We are also geared up for working cross-border like no other firm; in view of our cooperation with DLA Piper, our team works as one across 90+ offices to support clients anywhere in the world. We have the ability to deploy within hours, through our own offices, locally and internationally qualified lawyers who work together on a daily basis.
Our regulatory lawyers in Brazil have already advised several businesses on the regulatory issues which impact the manufacture, R&D, and marketing of biologics, biotech, and biosimilar products. We have experience with both human and animal health regulatory issues affecting health-regulated products. Our local presence in key markets for this sector enables our regulatory team to exchange information unique to the problems being faced by the industry in different jurisdictions.
Our tax group assists clients in structuring a wide range of transactions, from private equity deals to corporate acquisitions, reorganizations, and disposals. Throughout the world, Campos Mello Advogados, in cooperation with DLA Piper, also offers our clients sophisticated, innovative, and creative tax and business planning advice in connection with domestic and multi-jurisdictional transactions and investments. We provide these international tax services while at the same time offering clients the benefits of attorney-client and work product privileges.
Our mergers, acquisitions, and transactional lawyers have extensive experience structuring, financing, negotiating, documenting, and closing deals involving Life Sciences, Healthcare, and Cannabis companies. We have handled numerous mergers and acquisitions; acquisitions and sales of substantial healthcare assets; corporate restructuring; joint ventures and strategic alliances among providers, physicians, and payors; development of provider networks; secured loans; and structuring syndications and other securities transactions.
Our Commercial Contracts practice combines legal knowledge with deep sector experience and a can-do approach covering the full spectrum of commercial and business law issues. When it comes to multi-jurisdictional transactions, our worldwide presence and experience managing sophisticated cross-border commercial deals set us apart.
Our global technology transactions and strategic sourcing lawyers have the market knowledge, legal experience, and regional presence to provide you with the highest quality legal services worldwide. We focus on developing, protecting, exploiting, and using intellectual property and technology-related assets through the stages of a company’s growth and sourcing strategic investments and services for use in a company’s operations.
Personal information is an increasingly valuable – and increasingly risky – business asset. As businesses struggle to keep up with the critical, fast-changing data protection laws and face an increased risk of serious data breaches, Campos Mello Advogados, cooperating with DLA Piper, is uniquely positioned to help guide clients. With data protection lawyers around the globe, we can provide highly sophisticated data management, data security, and privacy law advice wherever our clients do business.
Our fully integrated multi-disciplinary team is accustomed to working with clients on cross-border issues or, by contrast, simply on regulatory challenges in a single jurisdiction. Businesses operating in the Life Sciences, Healthcare, and Cannabis industries often face significant regulatory burdens. We help clients in this space navigate a rapidly evolving landscape of rules and regulations. We constantly monitor policy changes and the impact it is having on the industry, including innovative policies or guidance on processes, technologies, and sustainability solutions (importantly, both for the reverse logistic of packaging of drugs and the reusability/recyclability of materials).
We help clients avoid investigations and ensure that their compliance programs with the numerous statutes and regulations that govern life sciences, healthcare, and medicinal cannabis operations. We understand how enforcement decisions are made and represent clients who are the target of an investigation, facing allegations that they committed fraud, or are the victims of the fraud committed by others.
Although the specific factors from the sustainability, environmental, social, and governance (SESG) perspective in the life science, healthcare, and cannabis industry differ from those of other industries, creating new and sustainable value in this sector space will depend upon how companies address relevant SESG risks.
Based on our experience in the sector, we believe (and focus on) the following sustainability-related themes to be the core SESG issues that will continue to affect life science businesses such as access and affordability, supply chain compliance, business ethics, transparency and access to clinical trials, net-zero decarbonization and optimization of processes.
Access and learn about our Representative Matters.
Click and follow us on LinkedIn!
Created by NoblindDZ